SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended.......September 30, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from....... to.......
Commission file number..................0-13591
PROVIDENT AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania 23-2214195
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2500 DeKalb Pike, Norristown, Pennsylvania 19401
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (610) 279-2500
Former name, former address and former fiscal year, if changed since last
report: N/A
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes _X_ No
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date: 12,944,393 shares of common
stock, par value $.10, outstanding as of November 3, 1999.
Page 1 of 35 Pages
PROVIDENT AMERICAN CORPORATION
INDEX
Page No.
--------
Part I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Consolidated Statements of Operations 3
Consolidated Balance Sheets 4-5
Consolidated Statements of Changes in Stockholders' Equity 6
Consolidated Statements of Cash Flows 7-8
Notes to Condensed Consolidated Financial Statements 9-22
Item 2. Management's Discussion and Analysis of Results
of Operations and Financial Condition 23-32
Recent Sales of Unregistered Securities 32-33
Part II. OTHER INFORMATION
Items 1- 5 34
Reports on Form 8-K 34
SIGNATURES 35
Exhibit 11
Exhibit 27
Page 2 of 35 Pages
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Provident American Corporation and Subsidiaries
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share data)
3 Months Ended September 30, 9 Months Ended September 30,
1999 1998 1999 1998
---- ---- ---- ----
Revenue:
Premium: Accident and health, gross $ 21,772 $ 28,229 $ 71,068 $ 84,092
Life and annuity, gross 1,521 1,897 4,892 6,473
--------- --------- --------- ---------
Total gross premium 23,293 30,126 75,960 90,565
--------- --------- --------- ---------
Accident and health reinsurance ceded 21,007 12,740 68,803 37,545
Life and annuity reinsurance ceded 328 76 1,145 150
--------- --------- --------- ---------
Total reinsurance ceded 21,335 12,816 69,948 37,695
--------- --------- --------- ---------
Net premium 1,958 17,310 6,012 52,870
Net investment income 663 947 2,276 2,853
Realized gains (losses) on investments - 251 (65) 264
Gain (loss) on the sale of subsidiaries (9,528) - (8,028) 4,000
Other revenue 176 3 693 24
--------- --------- --------- ---------
Total revenue (6,731) 18,511 888 60,011
--------- --------- --------- ---------
Benefits and expenses:
Death and other policy benefits:
Life 1,181 948 3,911 3,433
Accident and health, net of reinsurance 1,365 9,640 3,937 31,517
Annuity contracts and other considerations 225 188 323 359
Increase (decrease) in liability for future policy benefits (40) 714 259 190
Commissions, net of ceding allowance and deferred acquisition 560 1,821 1,264 7,145
costs
Other operating expenses, net of ceding allowance
and deferred acquisition costs 7,021 7,587 15,458 17,510
Interactive sales and marketing expense 5,665 814 12,100 1,425
Amortization of deferred policy acquisition costs - 608 252 1,148
Interest expense 296 221 744 549
Depreciation and amortization of goodwill 552 251 1,273 685
--------- --------- --------- ---------
Total benefits and expenses 16,825 22,792 39,521 63,961
--------- --------- --------- ---------
Income (loss) before taxes and minority interest (23,556) (4,281) (38,633) (3,950)
Provision (benefit) for income taxes:
Current 3 (952) 21 (949)
Deferred - - - -
--------- --------- --------- ---------
Total income taxes 3 (952) 21 (949)
--------- --------- --------- ---------
Net income (loss) before minority interest (23,559) (3,329) (38,654) (3,001)
Minority interest in net loss of subsidiary (463) - (2,188) -
--------- --------- --------- ---------
Net income (loss) (23,096) (3,329) (36,466) (3,001)
--------- --------- --------- ---------
Dividends on preferred stock - 37 70 111
--------- --------- --------- ---------
Net income (loss) applicable to common stock (23,096) (3,366) (36,536) (3,112)
========= ========= ========= =========
Income (loss) per share of common stock
Basic $ (1.85) $ (0.33) $ (3.04) $ (0.31)
--------- --------- --------- ---------
Diluted $ (1.85) $ (0.33) $ (3.04) $ (0.31)
Common shares and equivalents used in computing income (loss) per
share
Basic 12,462,000 10,169,000 12,021,000 10,131,000
Diluted 12,462,000 10,169,000 12,021,000 10,131,000
See notes to consolidated financial statements.
Page 3 of 35 Pages
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets
(Dollars in thousands, except preferred and common stock data)
UNAUDITED
September 30, 1999 December 31, 1998
------------------ -----------------
Assets
Investments:
Securities available for sale $ - $ 31,880
Policy loans - 560
Other invested assets - 529
--------- ---------
Total Investments - 32,969
Cash and cash equivalents 25,924 26,185
Amounts due from third party administrator - 6,849
Premiums due and uncollected - 1,167
Amounts due from reinsurers - 22,222
Loans receivable from officer, director and stockholder - 1,328
Accrued investment income - 420
Prepaid interactive marketing expense 5,527 11,655
Property and equipment, less accumulated depreciation of $3,764 and $3,099 7,720 7,950
Unamortized deferred policy acquisition costs - 2,106
Goodwill, less accumulated amortization of $108 7,673 -
Other assets 1,434 3,838
Subsidiary assets available for sale 76,970 -
--------- ---------
Total Assets $ 125,248 $ 116,689
========= =========
Continued on next page.
See notes to consolidated financial statements.
Page 4 of 35 Pages
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets (Continued)
(Dollars in thousands, except preferred and common stock data)
UNAUDITED
September 30, 1999 December 31, 1998
------------------ -----------------
Liabilities and Stockholders' Equity
Liabilities:
Future policy benefits:
Life $ - $ 42,546
Annuity and other - 4,871
Policy claims - 42,481
Premiums received in advance and unearned - 335
Amounts due to reinsurers - 501
Accounts payable 1,171 2,107
Accounts payable to subsidiary 7,425 -
Accrued commissions and expenses 2,393 2,384
Loans payable - 3,865
Convertible debenture 24,528 -
Federal income taxes 585 1,222
Ceding commission liability 5,450 5,000
Deferred Loss on the sale of PILIC 8,400 -
Other liabilities 1,406 1,945
Subsidiary liabilities available for sale 76,970 -
--------- ---------
Total Liabilities 128,328 107,257
Commitments and Contingencies:
Minority Interest in HealthAxis.com, Inc.:
Minority interest in HealthAxis.com, Inc. common stock - 1,132
HealthAxis.com, Inc. preferred stock - Cumulative preferred stock,
par value $1:
authorized 5,000,000 shares:
Series B, issued 625,529 2,805 2,805
Series C, issued 1,526,412 and 0 7,845 -
Series D, issued 333,334 and 0 3,960 -
Stockholders' Equity:
Preferred stock, par value $1: authorized 20,000,000 shares:
Series A Cumulative convertible, issued 0 and 556,600 - 557
Series B Cumulative convertible, none issued - -
Common stock, par value $.10: authorized 50,000,000,
issued 12,944,393 and 11,488,911 1,294 1,149
Common stock, Class A, par value $.10: authorized 20,000,000, none issued - -
Additional paid-in capital 41,392 27,002
Accumulated other comprehensive income 39 666
Retained deficit (60,415) (23,879)
--------- ---------
Total Stockholders' Equity (17,690) 5,495
--------- ---------
Total Liabilities and Stockholders' Equity $ 125,248 $ 116,689
========= =========
See notes to condensed financial statements.
Page 5 of 35 Pages
Provident American Corporation and Subsidiaries
Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
(in thousands)
Preferred Stock Common Stock Additional
Paid-In Retained
Shares Amount Shares Amount Capital (Deficit)
------ ------ ------ ------ ------- ---------
BALANCE, DECEMBER 31, 1998 557 $ 557 11,489 $ 1,149 $ 27,002 $ (23,879)
Comprehensive income:
Net income (loss) (36,466)
Other comprehensive income (loss)
Comprehensive income
Issuance of common stock 25 2 267
Stock options and warrants exercised 873 87 5,589
Increase in net assets in HealthAxis.com, Inc. 5,669
Warrants issued 2,364
Conversion of Preferred Stock (557) (557) 557 56 501
Cash dividends declared on preferred stock (70)
---- ----- ------ ------- -------- ---------
BALANCE, SEPTEMBER 30, 1999 0 $ 0 12,944 $ 1,294 $ 41,392 $ (60,415)
Accumulated
Other
Comprehensive
Income (Loss) Total
------------- -----
BALANCE, DECEMBER 31, 1998 $ 666 $ 5,495
Comprehensive income:
Net income (loss) (36,466)
Other comprehensive income (loss) (627)
(627)
---------
Comprehensive income (37,093)
---------
Issuance of common stock 269
Stock options and warrants exercised 5,676
Increase in net assets in HealthAxis.com, Inc. 5,669
Warrants issued 2,364
Conversion of Preferred Stock 0
Cash dividends declared on preferred stock (70)
----- --------
BALANCE, SEPTEMBER 30, 1999 $ 39 $(17,690)
See notes to consolidated financial statements.
Page 6 of 35 Pages
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Unaudited)
(Dollars in thousands)
9 Months Ended September 30,
1999 1998
-------- -------
Cash flows from operating activities
Net income (loss) $(36,466) $(3,000)
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Depreciation and amortization 9,599 693
Net realized (gain) on sale of subsidiary (1,500) (264)
Minority interest in net loss (2,188) (4,000)
Decrease (increase) in:
Property & equipment 2,022 -
Premium due and uncollected, unearned
premium and premium received in advance (61) (1,030)
Prepaid interactive marketing expense (3,620) -
Due to/from reinsurers (12,079) 437
Due from third party administrator 6,849 (7,220)
Deferred policy acquisition costs, net 2,106 (3,144)
Accrued investment income 191 116
Other assets, current and deferred income
taxes and other liabilities 399 (2,933)
Accrued commissions and expenses 1,267 (1,018)
Unearned ceding commissions and interest 450 -
Deferred loss on the sale of PILIC 6,636 -
Future policy benefits and claims (13,126) 2,091
-------- -------
Net cash used in operating activities (39,521) (19,272)
-------- -------
Cash flows from investing activities
Purchases of bonds - (2,674)
Purchases of equity securities - (85)
Sale of bonds 6,542 5,943
Sale of subsidiary - 4,000
Sale of investment in real estate - 1,154
Maturity of investments and loans 43 27
Loans to officer, director and shareholder 1,328 (63)
Purchase of HealthAxis stock (8,203) -
Purchases of property and equipment (1,654) (1,747)
-------- -------
Net cash provided by investing activities (1,944) 6,555
-------- -------
Continued on next page.
See notes to consolidated financial statements.
Page 7 of 35 Pages
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Continued)
(Dollars in thousands)
9 Months Ended September 30,
1999 1998
------- -------
Cash flows from financing activities
Withdrawals from contractholder deposit funds (400) (589)
Repayments of loans payable (1,465) (1,447)
Issuance of convertible debenture 26,846 -
Issuance of common stock - 92
Issuance of convertible note - 5,000
Issuance of HealthAxis common stock 6,192 -
Issuance of HealthAxis preferred stock 12,171 -
Exercise of stock options 6,168 -
Dividends paid on preferred and common stock (70) (111)
------- -------
Net cash from financing activities 49,442 2,945
------- -------
Increase (decrease) in cash and cash equivalents 7,977 (9,772)
Cash and cash equivalents, beginning of period 26,185 16,767
------- -------
Cash and cash equivalents, end of period $34,162 $ 6,995
------- -------
Supplemental disclosure of cash flow information:
Interest paid $ 455 $ 127
Non-cash investing activities
Sale of subsidiaries $(9,476) -
Capital lease obligations 154 -
Income taxes (refunded), net $(5,218)
Non-cash financing activities:
Issuance of warrants $ 3,230 $ 1,135
Exercise of options and warrants $ 1,177 -
Repayment of loans payable $(2,400) -
Issuance of HealthAxis.com, Inc. common stock - $ 5,107
See notes to consolidated financial statements.
Page 8 of 35 Pages
Provident American Corporation and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
Note A - General
The condensed consolidated financial statements have been prepared by
Provident American Corporation and subsidiaries (the "Company" or "Provident")
without audit, pursuant to the rules and regulations of the Securities and
Exchange Commission and reflect all adjustments which, in the opinion of the
Company, are necessary to present fairly results for the interim periods.
Certain financial information and footnote disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and
regulations, although the Company believes that the accompanying disclosures are
adequate to make the information presented not misleading. Results of operations
for the nine-month period ended September 30, 1999, are not necessarily
indicative of the results that may be expected for the year ending December 31,
1999.
These financial statements should be read in conjunction with the
financial statements and notes thereto contained in the Company's Annual Report
on Form 10-K/A for the year ended December 31, 1998.
Certain prior year amounts have been reclassified to conform with the
current presentation.
Provident American Corporation ("PAMCO") is a Pennsylvania corporation
organized in 1982 and regulated as an insurance holding company by the states in
which its wholly owned insurance company, Provident Indemnity Life Insurance
Company ("PILIC"), is licensed. The operations of the Company are principally
those of its majority-owned subsidiary HealthAxis.com, Inc. ("HealthAxis") and
its Insurance Operations as defined herein.
HealthAxis was formed on March 26, 1998 to sell insurance products on
the Internet. HealthAxis is a subsidiary of Provident American Corporation,
which owns 79.8% of HealthAxis' capital stock. PAMCO and HealthAxis were in the
process of negotiating the terms of a merger whereby HealthAxis would be merged
with and into HealthAxis Acquisition Corp., a wholly-owned subsidiary of
Provident, and PAMCO would be the surviving publicly-traded company, with
HealthAxis being a wholly owned subsidiary. On October 28, 1999 HealthAxis
announced that discussions relating to the upstream merger with its parent have
been put on hold pending the outcome of discussions with an undisclosed third
party regarding a potential business combination. If the discussions result in a
binding agreement regarding a business combination, it is expected that the
transaction will be subject to various conditions and contingencies. In light of
these recent developments Provident and HealthAxis have decided to suspend
indefinitely their previously announced intention to merge until such time that
both companies can reassess their strategic alternatives with greater clarity.
Page 9 of 35 Pages
The Company's Insurance Operations are conducted through its wholly
owned life insurance subsidiary PILIC and PILIC's subsidiaries which during 1996
through 1998 were Provident American Life and Health Insurance Company
("PALHIC"), Montgomery Management Corporation ("MMC") and NIA Corporation
("NIA"). Hereinafter PILIC and all of its subsidiaries are referred to as the
Company's Insurance Operations. During 1998, the Company sold 80% of MMC's
outstanding common stock and on December 31, 1998 sold 100% of the outstanding
common stock of PALHIC and NIA. During the first quarter of 1999 the Company
sold the remaining 20% of MMC's common stock. As described in Note K, the
Company has entered into a definitive agreement to sell PILIC.
Note B - Losses and Uncertainties
The Company has incurred costs to develop and enhance its technology,
to create and introduce its website and to establish marketing, insurance
carrier and claims administration relationships. As a result, the Company has
incurred significant losses and expects to continue to incur losses on a
quarterly and annual basis at least through the next 18 months. The Company
currently intends to substantially increase its operating expenses as a result
of its strategic alliances, to fund increased interactive sales and marketing,
to enhance its existing web site and to fund increased salaries and other costs.
Consequently, the Company expects negative cash flow from operations to continue
for the foreseeable future as it continues to develop and market its
Internet-based health and life insurance business.
During 1999, HealthAxis completed a private offering of approximately
$8,800 of HealthAxis Series C Preferred Stock on March 30, 1999 (described in
Note H), approximately $6,200 of HealthAxis Common Stock (described in Note F)
on May 11, 1999, and approximately $4,000 of HealthAxis Series D Preferred Stock
(described in Note I) on July 12, 1999. The net proceeds have been used to and
are anticipated to be used to fund amounts due under HealthAxis' distribution
agreements with America Online, Inc. ("AOL"), Lycos, Inc. ("Lycos"), CNet, Inc.
("CNet") and Snap! LLC ("Snap") and an Advertising Agreement with Yahoo! through
the end of fiscal 1999 with the balance intended to be used by HealthAxis for
its working capital and other general purposes. The Company believes that the
above net proceeds together with its current cash and cash equivalents will be
sufficient to fund HealthAxis' current operations through the first quarter of
2000. However, subsequent equity or debt financings will be necessary to enable
the Company to fund amounts due to AOL in the event that HealthAxis elects to
exercise its option to renew its agreement with AOL, payments to Lycos, CNet and
Snap, future operations and continue to implement its current business
strategies.
The Company has incurred losses in its Insurance Operations during 1999
and in prior years and is pursuing the sale of PILIC as described in Note K. On
September 15, 1999 the Company issued 2% Convertible Debentures ("Debentures")
in the amount of $27,500 as described in Note J. The net proceeds have been used
and are anticipated to be used for working capital and other general corporate
purposes, including approximately $8,203 to purchase HealthAxis Common Stock as
described in Note F, $14,700 to sell the Insurance Operations and retain the
Company's home office and 445,916 shares of HealthAxis Series A Preferred Stock
as described in Note K, thereby completing the Company's transition from
insurance underwriter to an internet insurance agency.
Page 10 of 35 Pages
Note C - Changes in Web Alliances
On April 14, 1999, the Company and CNet amended the Promotion Agreement
dated June 14, 1998, as amended on November 13, 1998 (the "Amended Agreement")
to, among other things, revise the current payment schedule, to remove Snap as a
party to the agreement and enter into a separate agreement with Snap, as CNet
and Snap are now separate entities. The Amended Agreement and the Snap Agreement
extends the termination date of the initial term of the agreement to August 31,
2000; allocates the total number of monthly impressions between Snap and CNet;
provides CNet and Snap with the ability to immediately terminate the Amended
Agreement and Snap Agreement for nonpayment of fees due or to charge interest on
all unpaid amounts at a rate of 1-1/2% per month; revises the exclusivity
provisions of the Snap Agreement; and revises the payment schedule applicable to
the optional term. Note D - Prepaid Interactive Marketing Expense
During 1999, HealthAxis made payments aggregating $3,620 to AOL, Lycos,
CNet, Snap and Yahoo!, $3,370 of which have been charged, to prepaid interactive
marketing expense and $250 of which reduced accrued expenses. Included in Sales
and marketing expense is amortization of prepaid interactive marketing expense
of $9,367 consisting of exclusivity expense and impression advertising of $2,390
and $6,977, respectively for 1999.
Note E - HealthAxis Warrants Issued and Commitments in Connection with Alliance
Agreements
During 1999, in connection with its amended Carrier Partner agreement
with UICI, HealthAxis agreed to issue UICI a warrant to purchase 150,000 shares
of HealthAxis Common Stock at an exercise price of $4.40 per share with a
five-year term. This warrant has been valued at $505, recorded as prepaid
alliance agreement expense included in other assets and will be expensed over
the life of the agreement beginning July 1, 1999. In the event AOL exercises its
redemption rights set forth in the Certificate of Designation related to the
Series B Preferred Stock, UICI shall receive a warrant to purchase an additional
200,000 shares of HealthAxis' Common Stock at an exercise price of $3.00 per
share.
In May 1999, HealthAxis entered into a Strategic Alliance Agreement
with First Health Group Corp. ("First Health"). In conjunction with this
agreement, HealthAxis issued a warrant to First Health for 50,000 shares of
HealthAxis Common Stock at $20.00 per share with a three-year term. Of that
amount, warrants to purchase 10,000 shares are immediately exercisable, have
been valued at $84 and recorded as prepaid alliance agreement expense included
in other assets. The remaining warrants become exercisable at the rate of 10,000
warrants upon the signing of each sub-client agreement with each carrier, until
the fourth carrier is signed. In addition, if the average daily closing price of
HealthAxis' Common Stock is $50.00 per share for a period of 60 consecutive
calendar days and if no sub-client agreement has been executed, 10,000 shares
subject to this warrant which are not exercisable shall become exercisable in
full.
In July 1999, HealthAxis issued a warrant for 75,000 shares of
HealthAxis Series D Preferred Stock at $14.50 per share with a five-year term in
conjunction with a Strategic Alliance Agreement with Intel Corporation. Half of
these warrants become exercisable in January 2000, with the remaining warrants
becoming exercisable in July 2000.
Page 11 of 35 Pages
HealthAxis has entered into an Interactive Marketing Agreement with AOL
and promotional agreements with CNet, Snap and Lycos. In connection with these
agreements HealthAxis has paid $15.5 million in cash and warrants as of
September 30, 1999 and is required to pay additional amounts as described in
Notes D, E, F and O to the Company's Consolidated Financial Statements for the
period ended December 31, 1998.
In August 1999, HealthAxis entered into an Advertising Agreement with
Yahoo! for a campaign which began in September 1999 and ends on January 31st
2000. In connection with this agreement, the Company has paid, and recorded as
prepaid marketing expense, $150 as of September 30, 1999 and is required to pay
an additional $575 at a rate of $125 a month, with $75 due in January 2000.
Note F - Goodwill and Minority Interest in HealthAxis.com, Inc.
The Company has accounted for the portion of HealthAxis owned by
outside parties as Minority Interest in HealthAxis. The chart below identifies
the equity ownership of HealthAxis Common Stock and quantifies the Company's
majority interest and the minority interest in HealthAxis Common Stock.
September 30, 1999 December 31, 1998
-------------------------------- --------------------------------
Shares Percentage Shares Percentage
---------- ---------- ---------- ----------
PAMCO 15,222,395 90.9% 13,807,395 85.4%
Minority Interest 1,516,416 9.1% 2,365,365 14.6%
---------- ------ ---------- ------
Total 16,738,811 100.0% 16,172,760 100.0%
========== ====== ========== ======
The aforementioned outstanding shares of HealthAxis Common Stock
exclude options and warrants to purchase HealthAxis Common Stock and HealthAxis
convertible preferred stock convertible into HealthAxis Common Stock.
On May 11, 1999, HealthAxis completed a private placement of 516,051
shares of HealthAxis Common Stock to a group of accredited investors at $12 per
share for an aggregate purchase price of $6,193, less issuance costs of $2. The
net proceeds of $6,191, have and will be used by HealthAxis for working capital
and other general corporate purposes, including marketing expenses, web site
enhancements, salary expenses and advertising and promotional expenses.
Investors purchasing HealthAxis Common Stock were provided with registration
rights described in the Company's Form 8-K filed on May 14, 1999.
On May 13, 1999, PAMCO entered into a Stock Purchase Agreement for the
purchase of 1,415,000 shares of HealthAxis Common Stock from HealthPlan Services
for $7,040 to close on or before June 30, 1999. PAMCO did not close on or before
June 30, 1999 and paid HealthPlan Services a late fee of $100 to extend closing
until July 30, 1999. If the closing did not occur by July 30, 1999, the Stock
Purchase Agreement provided that the purchase price per share would increase by
8-1/2% per-month until closing, which closing was required to occur on or before
November 1, 1999. PAMCO completed the purchase of these shares in November 1999
and paid an aggregate of $8,203 for such shares (including late fees). The
Company has accounted for the excess of the purchase price over the reduction to
minority interest as goodwill to be amortized straight-line over 3 years.
Page 12 of 35 Pages
The Company has accounted for the 545,916 shares of HealthAxis
cumulative preferred stock, par value $1 Series A ("Series A Preferred Stock")
purchased by PILIC in 1998 for an aggregate consideration of $2,400, or $4.40
per share, as an investment in HealthAxis. The Series A Preferred Stock is
convertible into HealthAxis Common Stock on a one for one basis, subject to
adjustment. Each share of Series A Preferred Stock has the same voting rights as
a share of HealthAxis Common Stock into which it is convertible and has certain
preferences with respect to the payment of dividends and upon liquidation over
HealthAxis Common Stock. See Note K regarding Series A Preferred Stock
transferred in connection with the sale of PILIC.
The Company has also accounted for the net proceeds of HealthAxis
cumulative preferred stock, par value $1 Series B ("HealthAxis Series B
Preferred Stock") as described in Note G, Series C ("HealthAxis Series C
Preferred Stock") as described in Note H and Series D ("HealthAxis Series D
Preferred Stock") as described in Note I as minority interest.
Note G - HealthAxis.com, Inc. Series B Cumulative Convertible Preferred Stock
During 1998, HealthAxis issued 625,529 shares of HealthAxis Series B
Preferred Stock to AOL at $4.40 per share for an aggregate purchase price of
$2,750, less issuance costs amounting to $51, of which a portion of such net
proceeds was used to pay amounts due to AOL under the Interactive Marketing
Agreement. The terms of the HealthAxis Series B Preferred Stock are described in
the Company's Form 8-K filed on December 23, 1998.
Dividends. As of September 30, 1999, HealthAxis accrued $105 of unpaid
dividends on Series B Preferred Stock. Prior to March 30, 1999, holders of the
Series B Preferred Stock were entitled to cumulative dividends accruing from the
date of issuance, as and if declared by the HealthAxis board of directors out of
funds legally available therefor, at the annual rate of $.13 per share (subject
to equitable adjustment to reflect stock splits, stock dividends, stock
combinations, recapitalizations and similar occurrences).
Optional Redemption. Holders of the HealthAxis Series B Preferred Stock
have the option, exercisable upon request of the holders of 51% of the
outstanding shares of HealthAxis Series B Preferred Stock within six months
after the later of the occurrence of a Trigger Event (as defined below) or
notice of a Trigger Event, to cause HealthAxis to redeem any or all of the
shares of HealthAxis Series B Preferred Stock requested to be redeemed, at a
redemption price per share equal to the original issuance price (subject to
adjustment to reflect stock splits, stock dividends, stock contributions,
recapitalizations and similar occurrences) plus an amount that would yield a
total annualized return of 10% calculated daily and compounded annually from the
later of either the original issuance date or the date on which the holder
acquired the shares of HealthAxis Series B Preferred Stock through the date of
redemption. Notice of the exercise of the optional redemption rights with
respect to the HealthAxis Series B Preferred Stock must be given to HealthAxis
pursuant to the notice of optional redemption provision contained in the
Certificate of Designation related to the HealthAxis Series B Preferred Stock.
Page 13 of 35 Pages
A "Trigger Event" means: (i) January 31, 2002, if by that date,
HealthAxis has not consummated an underwritten public offering of newly issued
HealthAxis Common Stock pursuant to a registration statement filed under the
Securities Act, at a net offering price per share of HealthAxis Common Stock
that represents a pre-offering market capitalization of not less than $150,000
and with aggregate proceeds of not less than $25,000, (ii) failure to renew by
HealthAxis or a material breach by any party other than AOL or termination of
the IM Agreement with AOL, (iii)the date of the occurrence of a liquidation of
HealthAxis, (iv) March 31, 1999, if by that date, HealthAxis has not consummated
an equity financing yielding aggregate gross proceeds to HealthAxis of not less
than $7,000 at a price per share of at least $3.74 (a "Qualified Financing"), or
(v) May 31, 1999, if by that date, HealthAxis has not consummated an equity
financing yielding aggregate gross proceeds to HealthAxis of not less than
$3,500 at a price per share of at least $3.74 (a "Second Qualified Financing").
As described in Note G, HealthAxis completed an equity financing in the amount
of $8,807 as of March 30, 1999 and as described in Note F HealthAxis completed
an equity financing in the amount of $6,193 on May 11, 1999.
Note H - HealthAxis.com, Inc. Series C Cumulative Convertible Preferred Stock
On March 30, 1999, HealthAxis issued 1,526,412 shares of HealthAxis
Series C Preferred Stock to a group of accredited investors at $5.77 per share
for an aggregate purchase price of $8,807, less issuance costs of $684 and the
value of warrants to purchase HealthAxis common stock issued in connection with
the issuance of HealthAxis Series C Preferred Stock to certain professional
service firms valued at $278. The net proceeds of $8,123 have and will be used
for working capital and other general corporate purposes, including marketing
expenses, web site enhancements, salary expenses and advertising and promotional
expenses of HealthAxis.
The terms of the HealthAxis Series C Preferred Stock are described in
the Company's Form 8-K filed on April 30, 1999.
Note I - HealthAxis.com, Inc. Series D Cumulative Convertible Preferred Stock
On July 12, 1999, HealthAxis issued 333,334 shares of HealthAxis Series
D Preferred Stock to Intel Corp at $12 per share for an aggregate purchase price
of $4,000, less issuance costs of $40. The net proceeds of approximately $3,960,
will be used for working capital and other general corporate purposes, including
marketing expenses, web site enhancements, salary expenses and advertising and
promotional expenses of HealthAxis.
In connection with the HealthAxis Series D Offering, HealthAxis'
Amended and Restated Articles of Incorporation were amended to authorize an
additional 500,000 shares of HealthAxis Preferred Stock.
The terms of the HealthAxis Series D Preferred Stock are described in
the Company's Form 8-K filed July 26, 1999.
Page 14 of 35 Pages
Note J - Convertible Debentures
On September 15, 1999 the Company issued 2% Convertible Debentures
("Debentures") in the amount of $27,500 due September 14, 2002. The Debentures
bear interest at the rate of 2% per annum, payable in cash or equivalent value
of the Company's Common Stock, semi annually on January 1 and July 1 (the
"Interest Payment Date") of each year, beginning on January 1, 2000. Accrued,
unpaid and past due amounts bear interest at the rate of 15% per annum (the
"Default Rate"). Except with respect to overdue interest it is assumed that the
Company will make all payments of interest in Common Stock, unless the Company
notifies the holder in writing otherwise. The Debentures are convertible into
the Company's Common Stock at a conversion price of $20.34 per share (the
"Conversion Price"), which represented a 15% premium over the average of the
closing price of $18.00 per share on September 13, 1999 and $17.375 per share on
September 14, 1999. As part of the Transaction, the Company issued to the
Purchasers warrants to purchase 202,802 shares of its Common Stock at an
exercise price equal to the Conversion Price ($20.34 per share) (the
"Warrants"). The Warrants have a term of five years, were valued at $2,317 and
have been accounted for as a cost of issuing the Debentures. The cost of issuing
the Debentures of $3,052 consisted of the value of the Warrants and other costs,
which will be amortized over the anticipated life of the Debentures as interest
expense.
In a separate but related transaction Alvin H. Clemens, Chairman of the
Company, among other things, has assigned to the Company options to purchase
202,802 shares of Common Stock. The net result of this assignment is that the
number of Warrants issued to the purchasers of the Debentures is equal to the
number of options retired by Mr. Clemens. Reference is made to Note N herein.
The securities issued pursuant to this transaction are exempt from the
registration requirements of the Securities Exchange Act of 1933 (the
"Securities Act"), as provided under Rule 506 and under Section 4(2) of the
Securities Act. As part of the transaction the Company executed a Registration
Rights Agreement. The Company is required to file a Form S-3 Registration
Statement to cover all Registrable Securities (as defined) to be made on a
continuous basis pursuant to a "Shelf" registration statement under Rule 415 of
the Securities Act. Subject to certain limitations the registration statement is
to remain effective until four years from the date the registration statement is
declared effective by the Securities and Exchange Commission. There is also a
one time Underwritten Registration obligation. If at any time the Registrable
Securities are not covered by an effective registration statement, and the
Company files a registration statement relating to an offering of its equity
securities, the Company is required to notify the holders of Registrable
Securities of the filing and will use reasonable efforts to effect piggy-back
registration of the Registrable Securities requested to be registered by the
holder, subject to certain existing piggy-back rights. In the event the Company
does not fulfill obligations under this agreement, it is subject to certain
financial penalties.
The terms of the transaction are described in the Company's Form 8-K
filed on September 22, 1999.
Page 15 of 35 Pages
Note K - Sale of PILIC to AHC Acquisition Corporation
On August 16, 1999 the Company entered into a definitive agreement (the
"Stock Purchase Agreement") to sell its insurance subsidiary, PILIC, to
Provident's Chairman, Alvin H. Clemens. Under the terms of the agreement, the
Company will sell all of the issued and outstanding shares of the common stock
of PILIC to AHC Acquisition, Inc. ("AHC"), a newly formed Pennsylvania business
corporation, all of the stock of which is owned by Mr. Clemens. The transaction
is subject to the approval of the boards of directors of all parties to the
transaction (which has occurred), the shareholders of the Company, the
Pennsylvania Department of Insurance, as well as the receipt by the Board of the
Company of a fairness opinion. The First Amendment to Stock Purchase Agreement,
executed on October 27, 1999, removed the requirement for the Company's
shareholders to approve the transaction.
The Board of Directors of the Company received the fairness opinion of
Advest, Inc., a subsidiary of The Advest Group, Inc., dated October 20, 1999
(the "Fairness Opinion"). The Fairness Opinion cites the financial terms of the
transaction, and notes that the PILIC shares proposed to be purchased by AHC
will continue to be subject to the Stock Pledge Agreement dated December 29,
1998 by the Company in favor of Reassurance Company of Hannover. The Fairness
Opinion further discusses the information which was reviewed in arriving at the
Fairness Opinion, which includes a number of agreements between the Company and
other persons, and various reports made by the Company on Forms 10-K and 10-Q
for the calendar years 1997, 1998 and for the period ending June 30, 1999,
together with statutory financial statements and related footnotes of PILIC for
the years ended December 31, 1996, 1997, 1998, and the quarterly statement as of
June 30, 1999. The Fairness Opinion concludes that the financial terms of the
transaction are fair, from a financial point of view, to the Company and its
shareholders.
The terms of the Stock Purchase Agreement require the Company to
purchase PILIC's home office building for $4.7 million and the Company to
purchase 545,916 shares of HealthAxis Stock at a purchase price equal to $4.71
per share plus interest at the rate of 8% per annum thereon from the date of
acquisition of such shares by PILIC through the date of such sale. The
difference between the $14.7 million required payment amount and the sum of
purchase price of the building and the HealthAxis Stock will be a capital
contribution from the Company to PILIC to be paid at or before closing. In
addition, the terms of the Stock Purchase Agreement require the Company to
transfer 100,000 shares of the HealthAxis Stock to AHC together with
registration rights previously granted to PILIC. The terms of the Stock Purchase
Agreement further require the Company to assume all of PILIC's employees and
related employee obligations and that PILIC shall have no employees at closing.
The Company anticipates entering into an employee leasing arrangement with PILIC
whereby PILIC will reimburse the Company for the Company's out of pocket
employee costs related to services provided on PILIC's behalf. The Stock
Purchase Agreement provides that any cost associated with the termination of
certain executives along with certain taxes incurred by PILIC prior to the
effective date in connection with any of the transactions contemplated in the
Stock Purchase Agreement shall be borne by the Company. Pursuant to the Stock
Purchase Agreement closing is to occur on or before December 31, 1999. The Stock
Purchase Agreement further requires the Company to lease to PILIC office space,
furniture and equipment for a period of up to one year at no cost.
Page 16 of 35 Pages
The Stock Purchase Agreement includes various warranties,
representations, covenants and conditions, including but not limited to certain
non-compete and non-solicitation agreements with AHC regarding the future sale
of health insurance products for a three-year period commencing on December 31,
1998 by licensed insurance agents of PILIC. Notwithstanding the foregoing,
HealthAxis, and its affiliates (as defined therein) may freely solicit the sale
of and distribute health and all other types of insurance products on behalf of
any person or entity through Internet websites, or other means of electronic
commerce, including but not limited to, sales of such products on behalf of
PILIC or AHC pursuant to the Individual Medical Products Carrier Partner
Agreement among PALHIC, and HealthAxis dated December 29, 1998 and the Carrier
Partner Agreement among PALHIC and HealthAxis dated December 14, 1998.
Upon the Company's fulfillment of its obligations to PILIC prior to the
closing, together with the completion of the closing, the Company will have no
liability with respect to PILIC's ongoing insurance business, capital and
surplus, and business operations, except for the liability of the Company and
its successors under the Company Guaranty Agreement with the Reassurance Company
of Hannover ("RCH"), the Stock Pledge Agreement with RCH, the Provident American
Life and Health Insurance Company ("PALHIC") Purchase Agreement together with
the ceding commission liability recorded on the Company's books in connection
with agreements with RCH and the Company's obligation to lease to PILIC office
space, furniture and equipment.
The Company has recorded a loss on the sale of subsidiary of $9,528 in
connection with the sale of PILIC which includes a write-off of unamortized
deferred policy acquisition costs, property and equipment, net of accumulated
depreciation and certain other assets in the amount of $1,128 together with a
deferred loss on the sale of PILIC liability from the sale of PILIC representing
the required capital contribution and value of the Series A Preferred Stock
transferred to AHC net of liabilities already recorded. The results of
operations and the net assets or liabilities of the Insurance Operations will be
reported as discontinued operations effective with obtaining the necessary
regulatory approvals. The following table list assets and liabilities available
for sale:
UNAUDITED
Assets Sept. 30, 1999
Investments: --------------
Securities available for sale $24,136
Policy loans 558
Other invested assets 488
-------
Total Investments 25,182
Cash and cash equivalents 8,238
Accounts receivable from parent 7,425
Premiums due and uncollected 899
Amounts due from reinsurers 34,448
Accrued investment income 229
Other assets 549
-------
Total Assets $76,970
=======
Page 17 of 35 Pages
UNAUDITED
Sept. 30, 1999
Liabilities: --------------
Future policy benefits:
Life $43,165
Annuity and other 4,273
Policy claims 28,934
Other liabilities 598
-------
Total Liabilities $76,970
=======
No assurances can be given as to whether or not the transactions will
be completed or the receipt of required regulatory approvals. If the Company
does not receive all necessary required approvals, Stock Purchase Agreement and
the sale of PILIC to AHC will be terminated.
Note L - Reinsurance and Deferred Acquisition Cost Impact on Benefits and
Expenses
Accident and health policy benefits, commissions and other operating
expenses are net of the following ceded reinsurance and deferred acquisition
cost amounts:
3 Months Ended Sept. 30, 9 Months Ended Sept. 30,
1999 1998 1999 1998
------- ------- ------- -------
Accident and health benefits
Gross before reinsurance ceded $21,227 $21,513 $56,185 $62,542
Less reinsurance ceded 19,862 11,872 52,248 31,025
------- ------- ------- -------
Net of reinsurance $ 1,365 $ 9,641 $ 3,937 $31,517
======= ======= ======= =======
Commissions
Gross before reinsurance ceded $ 3,098 $ 1,895 $10,748 $16,778
Less reinsurance ceded 2,576 (766) 9,171 6,509
Less deferred acquisition costs (38) 839 313 3,124
------- ------- ------- -------
Net $ 560 $ 1,822 $ 1,264 $ 7,145
======= ======= ======= =======
Other operating expenses
Gross before reinsurance ceded $ 7,040 $ 9,514 $15,552 $23,198
Less reinsurance ceded 19 1,458 56 4,520
Less deferred acquisition costs - 468 38 1,168
------- ------- ------- -------
Net $ 7,021 $ 7,587 $15,458 $17,510
======= ======= ======= =======
Effective December 31, 1998, the Company and PILIC signed an agreement
to reinsure 100% of its group medical and group life inforce business and sell
the Company's group medical marketing, sales distribution rights and all of the
outstanding capital stock of PALHIC to Central Reserve Life Insurance Company
("CRLC") (the "CRLC Agreement").
Page 18 of 35 Pages
Under the CRLC Agreement, PALHIC reinsured 100% of its business to
PILIC, which in turn reinsured through a 100% coinsurance agreement, all of the
Company's group medical and group life business to RCH. In addition, PILIC sold
all of the outstanding shares of PALHIC and NIA to CRLC for an amount equal to
PALHIC's capital and surplus. The Company transferred all rights and control
regarding the Company's licensed insurance agents and entered into a non-compete
and non-solicitation agreements with CRLC regarding the Company's licensed
insurance agents with respect to the future sale of health insurance products
for a three year period.
Effective December 31, 1998, PILIC entered into a coinsurance agreement
with RCH whereby PILIC received a $10,000 ceding commission which consisted of a
$5,000 non-refundable payment and a $5,000 payment contingent upon RCH's earning
at least $10,000 in future profits from the ceded inforce business, plus 12%
interest (the "guaranteed amount"). PILIC recognized the $10,000 as ceding
commission revenue net of transaction costs of $417 and PAMCO recognized a
$5,000 ceding commission liability because of the negative financial history of
the business. As a result of the transaction, PILIC wrote-off unamortized
deferred acquisition costs and restructuring costs aggregating $4,200.
If RCH fails to earn the guaranteed amount within five years of the
date of the closing of the CRLC transaction, PAMCO must repay RCH the lesser of
the guaranteed amount less RCH's actual profits on the inforce business, or
$5,000, plus 12% interest. In the unlikely event that future profits exceed the
guaranteed amount, then PILIC is entitled to receive an additional payment from
RCH equal to two-thirds of the policy fees collected during 1999 and one-third
of the policy fees collected during 2000.
As security for PAMCO's guarantee, PAMCO executed a security agreement
in favor of RCH secured by the stock of PILIC. This agreement provides that RCH
will take ownership of PILIC if the Company defaults on its guarantee to RCH.
PAMCO provided various affirmative covenants regarding corporate existence;
compliance with laws; furnishing various notices to RCH; inspection and audit
rights and insurance coverage. Additionally, PAMCO provided certain negative
covenants with regard to selling, assigning, leasing or otherwise disposing of
PAMCO or PILIC assets; entering into agreements materially and adversely
effecting PAMCO's or PILIC's ability to carry on business; entering into an
agreement materially and adversely effecting PAMCO or PILIC ability to perform
obligations under the Guaranty, the reinsurance agreement with RCH, the Stock
Purchase Agreement and other related agreements. There also exist various
provisions regarding PAMCO or PILIC incurring or creating indebtedness or
declaring dividends. As described in Note K, PAMCO's obligation to RCH remains
after PILIC's sale.
Under the CRLC Agreement, PILIC has the right to assume new business
written by PILIC's agents for five years after the effective date of the CRLC
Agreement. The Company has determined not to assume any business from CRLC.
During the first quarter of 1999, the Company decided to cease its
participation via assumption reinsurance of stop loss business administered by
MMC.
Page 19 of 35 Pages
Reinsurance does not relieve the Company of its primary obligations to
its policyholders and varies according to the age of the insured, type of risk
and type of policy. Retention amounts for life insurance range up to $50 of
coverage per individual life and for health insurance up to $85 per individual.
During 1998, the Company had Quota Share Reinsurance and Excess of Loss
Reinsurance arrangements on its group medical insurance with a group of
reinsurers which were terminated by the Company effective December 31, 1998 in
connection with the reinsurance and other agreements with RCH and CRLC.
The Company's medical quota share and excess reinsurance agreements
with Swiss Re were terminated effective December 31, 1997. Swiss Re's obligation
to assume its proportionate share of medical paid losses incurred prior to
January 1, 1998 remains in effect. The amount of reinsurance recoveries from
Swiss Re is currently in dispute and Swiss Re has refused further payment. The
Company has provided Swiss Re with a Notice of Default and has asserted its
rights under the reinsurance contract. The Company has recognized an allowance
for uncollectability for a portion of the amounts due from Swiss Re.
In addition, the Company generally assumes 30% (up to $150 per
individual) of the liability on its limited self-funded accident and health
business, which consists generally of policies issued to limit the claims
expenses of employers that self-insure group medical benefits with respect to
any individual employee and in the aggregate.
Note M - Settlement Agreement with HPS
Sale of Montgomery Management: Effective March 31, 1999 the Company
sold its remaining 20% of MMC common stock to HPS for a purchase price of
$1,500, payment of which was made by a set off of a like amount against future
service fees, accounted for a loan payable, owed by the Company to HPS. The
Company recognized a $1,500 pre-tax gain on the sale.
In a previous agreement, in February 1998 the Company sold for $4,000
49% of MMC common stock along with a warrant to purchase an additional 31% of
MMC's common stock for one dollar per share. Immediately prior to the sale MMC
declared a dividend payable to its parent PILIC equal to its total equity.
During the fourth quarter of 1998, the buyer exercised the warrant to purchase
the additional 31% of MMC's Common Stock for $8. The Company recognized a $4,000
pre-tax gain on the sale of MMC in 1998. Effective with the sale in 1998, the
Company includes MMC in the Company's consolidated financial statements on the
equity basis.
Page 20 of 35 Pages
Commitment to pay outstanding HPS service fees to HPS: In conjunction
with the sale of MMC described above, PAMCO entered into a settlement agreement
to resolve a number of disputes that had arisen between the Company and HPS
relative to HPS' performance of administrative services under the HPS
Outsourcing Agreement of the now ceded block of Provident health business. The
companies agreed to settle all differences and claims related to the HPS
Outsourcing Agreement and certain actions taken by HealthAxis regarding
HealthAxis' obligations under certain agreements between the parties. Also in
accordance with the terms of the settlement agreement, HPS exercised a warrant
granted in 1998 in connection with the HPS E-commerce Agreement, and purchased
100,000 shares of the common stock of PAMCO for a purchase price of $900. The
purchase price was paid by a set off of a like amount against the service fees
owed by the Company to HPS. The Company paid the remaining balance of the
services fees owed to HPS in the amount of $1,267 to HPS on June 30, 1999,
whereupon the Company's obligation to pay service fees was terminated.
Note N -Letter Agreement between the Company and Alvin H. Clemens
On September 9, 1999, the Company and Mr. Clemens, the Company's
Chairman, entered into an agreement whereby Mr. Clemens agreed to convert his
Series A Preferred Stock, amend his agreement to purchase 550,000 shares of the
Company's Series A Preferred Stock in exchange for an option to purchase the
Company's Common Stock, released all right, title and interest to options to
purchase 202,802 shares of the Company's Common Stock and a 1997 agreement to
grant options to Mr. Clemens to purchase shares of the Company's Series A
Preferred Stock successively upon each exercise by Mr. Clemens of his existing
option and each subsequently granted option to purchase shares of Series A
Preferred Stock from time-to-time. The exercise prices of the options to
purchase Common Stock range from $3.64 to $8.75 per share and have a weighted
average price per share of $4.56. In consideration of the aforementioned the
Company paid Mr. Clemens $650 which was accounted for as compensation expense.
Note O - Segment Information
The Company's operating segments are: HealthAxis, Insurance Operations
and PAMCO. PAMCO includes investment income, interest expense and general
expenses relating to corporate operations not allocated to the other segments
and amortization of goodwill. Allocations of investment income, interest expense
and certain general expenses are based on a number of assumptions and estimates,
and the business segments reported operating results would change if different
methods were applied. Certain assets are not individually identifiable by
segment and, accordingly, have been allocated by formulas. Segment revenues
include premiums and other policy charges and considerations, net investment
income, commissions and other income. Transactions between reportable operating
segments are accounted for under respective agreements, which are generally at
cost. Financial information by operating segment for revenues, income before
federal income taxes and minority interests, and identifiable assets is
summarized as follows:
Page 21 of 35 Pages
3 Months Ended Sept. 30, 9 Months Ended Sept. 30,
1999 1998 1999 1998
-------- ------- -------- -------
Revenues
HealthAxis $ 84 $ - $ 125 $ -
Insurance Operations (6,844) 18,489 734 59,945
PAMCO 29 22 29 66
-------- ------- -------- -------
Total $ (6,731) $18,511 $ 888 $60,011
======== ======= ======== =======
Pre-tax income
HealthAxis $ (8,990) $(2,207) (18,847) $(3,175)
Insurance Operations (13,717) (1,183) (17,883) 554
PAMCO (849) (891) (1,903) (1,329)
-------- ------- -------- -------
Total $(23,556) $(4,281) $(38,633) $(3,950)
========= ======= ======== =======
September 30,1999 December 31, 1998
----------------- -----------------
Assets
HealthAxis $ 15,947 $ 14,876
Insurance Operations 76,970 96,935
PAMCO 32,331 4,878
-------- --------
Total $125,248 $116,689
======== ========
Note P - Investment Considerations
In analyzing whether to make, or continue, an investment in the
Company, investors should consider, among other factors, certain investment
considerations more particularly described in the Company's Annual Report on
Form 10-K/A for the year ended December 31, 1998, a copy of which can be
obtained from the Company.
Note Q - Forward-looking Statements
The information contained in the Quarterly Report on form 10-Q for the
quarter ended September 30, 1999 contains forward-looking statements (as such
term is defined under Section 21E of the Securities Exchange Act of 1934 and the
regulations thereunder), including without limitation, statements as to trends,
management's beliefs, expectations or opinions, which are based upon a number of
assumptions concerning future conditions that ultimately may prove to be
inaccurate.
Such forward-looking statements are subject to risks and uncertainties
and may be affected by various factors, which may cause actual results to differ
materially from those in the forward-looking statements. Certain of these risks,
uncertainties and other factors are discussed in the Company's Annual Report on
Form on 10-K/A for the year ended December 31, 1998.
Page 22 of 35 Pages
Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.
Overview
During 1998 the Company revised its strategy to focus predominately on
HealthAxis, the Company's e-commerce insurance marketing subsidiary. In early
1998 the Company determined that the Internet provided the opportunity to sell
health and life insurance directly to consumers thereby reaching individuals at
a cost potentially lower than traditional agency marketing channels. In light of
the losses experienced in the Company's small group and managed care products
and the need to focus on HealthAxis and deploy capital to it, the Company
entered into various agreements to sell PILIC's subsidiaries (MMC, PALHIC and
NIA) and cede 100% of the group medical and group life business during 1998.
On December 31, 1998, the Company executed a series of transactions
whereby PALHIC reinsured 100% of its business to PILIC, which in turn reinsured
via a 100% co-insurance reinsurance agreement all of the Company's group medical
and group life business to the RCH. In addition, PILIC sold PALHIC and NIA to
CRLC, transferred all rights and control regarding the Company's agents and
entered into non-compete and non-solicitation agreements regarding the Company's
agents with respect to the future sale of health insurance products by agents
for a 3-year period.
During the second quarter of 1999 the Company announced that it was
pursuing the sale of its Insurance Operations. As described in Note K of the
Notes to Financial Statements, the Company has entered into a definitive
agreement to sell PILIC.
HealthAxis is an Internet-based distributor of health insurance
products. The Company believes it is the first fully transaction-enabled direct
distributor of individual and small group health insurance products. Currently
HealthAxis markets individual coverage in 22 states and short term and student
medical insurance in 43 states, with nationwide coverage planned. HealthAxis
anticipates offering a full range of health and life insurance products for
individuals and small groups, including policies for prescription drugs, vision
care, dental coverage, critical care, long-term care, long term disability and
life insurance. HealthAxis is building a nationwide product portfolio through
sourcing relationships with leading insurance companies ("Carrier Partners"),
including the following: Aetna, Aegon, WellPoint Health Networks, Fortis, UICI
and Security Life, among others. The Company anticipates that HealthAxis will
enter into additional agreements with other insurance companies. HealthAxis
markets to consumers through its website (www.healthaxis.com), strategically
selected Internet properties, Yahoo! and Snap and through the following with
which HealthAxis possesses exclusive marketing rights: AOL, Lycos and CNet.
On December 3, 1998, HealthAxis commenced a launch of its operational
web site with distribution principally via the AOL relationship. The Company
expanded its online reach with the commencement of additional distribution on
Lycos in May 1999 and CNet and Snap in June 1999.
Page 23 of 35 Pages
HealthAxis has experienced an increase in revenues during 1999 due to
increased traffic, additional products and website enhancements. In August 1999,
HealthAxis launched its second Carrier Partner, Fortis, adding two additional
products to the website. The Company anticipates launching two additional
Carrier Partners' products on its website during the fourth quarter of 1999.
Additional Carrier Partners and the Company's initial offering of small group
products are anticipated to be added during the first half of 2000. The Company
expects to expand its Carrier Partner relationships to be able to offer a choice
of carriers in each market. As additional Carrier Partners and products become
available on the site, the Company anticipates revenues to increase.
The Company had previously disclosed that it intended to engage in a
business combination involving HealthAxis by the end of fiscal 1999. PAMCO and
HealthAxis were in the process of negotiating the terms of a merger whereby
HealthAxis would be merged with and into HealthAxis Acquisition Corp., a
wholly-owned subsidiary of Provident, and PAMCO would be the surviving
publicly-traded company, with HealthAxis being a wholly owned subsidiary. On
October 28, 1999 HealthAxis announced that discussions relating to the upstream
merger with its parent have been put on hold pending the outcome of discussions
with an undisclosed third party regarding a potential business combination. If
the discussions result in a binding agreement regarding a business combination,
it is expected that the transaction will be subject to various conditions and
contingencies. In light of these recent developments Provident and HealthAxis
have decided to suspend indefinitely their previously announced intention to
merge until such time that both companies can reassess their strategic
alternatives with greater clarity.
Results of Operations
For the three months ended September 30, 1999 ("the current quarter")
the net (loss) applicable to Common Stock was ($23.1 million) or ($1.85) per
diluted share compared to a net (loss) of ($3.4 million) or ($0.33) per diluted
share for three months ended September 30, 1998 ("the same period last year").
The Company's net loss was the result of a realized loss on the sale of PILIC of
$9.5 million as described in Note K of the Notes to Financial Statements and
increased expenses in both HealthAxis and the Insurance Operations.
After the closing on the sale of PILIC, the Company will no longer have
premium revenue, death and other policy benefits, commissions, net of ceding
allowance and deferred acquisition costs and amortization of deferred
acquisition costs. The Company will experience a reduction in net investment
income and other operating expenses, net of ceding allowances and deferred
acquisition costs.
Accident and health gross premium was $21.8 million for the current
quarter compared to $28.3 million for the same period last year. Accident and
health ceded premium was $21 million for the current quarter compared to $12.7
million for the same period last year. As a result of the transactions with CRLC
and RCH, the Company experienced a substantial decline in net earned premium in
comparison to 1998. Effective in 1999, the Company has ceded 100% of the
Company's small group and managed care premium to RCH. During the first quarter,
the Company also decided to cease its participation via assumption reinsurance
of stop loss business administered by MMC. The Company has also determined not
to assume any business from CRLC.
Page 24 of 35 Pages
Life and annuity premium, gross of $1.5 million for the current quarter
declined from $1.9 million for the same period last year due to reduced pre-need
premium. Life and annuity reinsurance ceded of $0.3 million increased from the
same period last year as a result of the transactions with CRLC and RCH.
Net investment income of $0.7 million in the current quarter decreased
from $0.9 million in the same period last year as a result of reduced bond and
short-term investment balances.
Accident and health, net of reinsurance expense of $1.4 million in the
current quarter decreased from $9.6 million in the same period last year as a
result of the transactions with CRLC and RCH, offset by greater than anticipated
claims experience on the Company's one life group medical business.
Commissions, net of ceding allowance and deferred acquisition costs of
$0.6 million in the current quarter decreased from $1.8 million in the same
period last year as a result of the transactions with CRLC and RCH.
Other operating expenses, net of ceding allowance and deferred
acquisition costs of $7.0 million for the current quarter decreased from $7.6
million in the same period last year primarily due to lower expenses in the
Company's Insurance Operations as a result of the transactions with CRLC and RCH
partially offset by an allowance for the Insurance Operations uncollectable
receivables and $2.2 million of higher expense associated with HealthAxis due
primarily to employee and recruiting expenses related to software engineering,
carrier integration, website enhancements, and general operations. To support
the HealthAxis business strategy, operating and development expenses will
increase as more carriers and products are integrated and website enhancements
are made.
Interactive sales and marketing expense of $5.7 million for the current
quarter increased from $0.8 million in the same period last year due primarily
to the amortization of HealthAxis' interactive marketing agreements based on the
number of impressions received by the website. Interactive marketing
amortization was $4.4 million for the current quarter. During the third quarter,
HealthAxis purchased impressions for $0.3 million from strategically selected
Internet properties. In addition, HealthAxis employee and recruiting expense
increased. The Company expects the impression amortization to increase as
additional carriers and products are introduced to the website. The number of
personnel and the amount spent on advertising through on-line and traditional
advertising will also increase in order to promote the HealthAxis' Internet
products.
For the nine months ended September 30, 1999 ("1999") the net (loss)
applicable to common stock was ($36.5) million or ($3.04) per diluted share
compared to net (loss) of ($3.1) million or ($0.31) per diluted share for nine
months ended September 30, 1998 ("1998"). The Company's net loss was the result
of a realized loss on the sale of PILIC as described in Note K of the Notes to
Financial Statements and increased expenses in both HealthAxis and the Insurance
Operations. The Company's results also included gains on the sale of MMC's
common stock in 1999 and 1998 as described in Note L of the Notes to the
Financial Statements.
Page 25 of 35 Pages
Accident and health gross premium was $71.1 million for 1999 compared
to $84.1 million for 1998. Accident and health ceded premium was $68.8 million
for 1999 compared to $37.6 million for 1998. As a result of the transactions
with CRLC and RCH, the Company experienced a substantial decline in net earned
premium in comparison to 1998.
Life and annuity premium, gross of $4.9 million for 1999 declined from
$6.5 million for 1998 due to reduced pre-need premium. Life and annuity
reinsurance ceded of $1.1 million increased from 1998 as a result of the
transactions with CRLC and RCH.
Realized loss on the sale of subsidiary in 1999 consisted of a $9.5
million loss on the sale of PILIC less a $1.5 million gain on the sale of MMC as
described in Notes K and L, respectively, of the Notes to Financial Statements.
Accident and health, net of reinsurance expense of $3.9 million in 1999
decreased from $31.5 million in 1998 as a result of the transactions with CRLC
and RCH offset by greater than anticipated claims experience on the Company's
one life group medical business.
Commissions, net of ceding allowance and deferred acquisition costs of
$1.3 million for 1999 decreased from $7.1 million in 1998 as a result of the
transactions with CRLC and RCH.
Other operating expenses, net of ceding allowance and deferred
acquisition costs of $15.5 million for 1999 decreased from $17.5 million in 1998
primarily due to lower expenses in the Company's Insurance Operations as a
result of the transactions with CRLC and RCH partially offset by an allowance
for the Insurance Operations uncollectable receivables and $5.5 million of
higher expense associated with HealthAxis due primarily to employee and
recruiting expenses related to software engineering, carrier integration,
website enhancements, and general operations.
Interactive sales and marketing expense of $12.1 million for 1999
increased from $1.4 million in 1998 due primarily to the amortization of
HealthAxis' interactive marketing agreements based on the number of impressions
received by the website. Interactive marketing amortization was $9.4 million for
1999 and $0.8 million in 1998. In addition, HealthAxis employee and recruiting
expense increased.
Liquidity and Capital Resources
A major objective of the Company is to maintain sufficient liquidity to
fund growth, fulfill statutory requirements and meet all cash requirements with
cash and short term equivalents plus funds generated from operating cash flow.
Page 26 of 35 Pages
During 1998, the Company's liquidity requirements were primarily
created and met by PILIC and PALHIC, along with the sale proceeds of MMC,
PALHIC, and NIA. During 1998 the primary sources of cash for the Insurance
Operations were premiums, investment income and investment sales and maturities.
During 1998 the primary uses of cash for the Insurance Operations were benefit
payments to insureds, operating costs including policy acquisition costs and
investment purchases. The primary sources of cash for HealthAxis were funds from
the issuance of debt and equity securities to outside parties and to PILIC. The
primary uses of cash for HealthAxis were operating costs and payments to AOL,
Lycos, Snap and CNet.
During 1999, the Company's liquidity requirements will be primarily
created and met by HealthAxis and PAMCO through the private placement of debt
and equity securities along with the sale of short and intermediate term
interest-bearing marketable securities in PILIC and, to a lesser degree,
individual life premiums, investment income and commissions and administrative
fees. The primary uses of cash for the Insurance Operations were claim payments
and associated general expenses related to the 1998 claim run-off, which have
been established as claim reserves, and life benefit payments to insureds and
life operating costs. The primary uses of cash for HealthAxis are operating
costs and payments to AOL, Lycos, Snap and CNet.
Cash and investments carried at market value at September 30, 1999
amounted to $59.3 million. This included $24.1 million of bonds issued by the
U.S. Government, government agencies, public utilities and other corporations,
$1.0 million invested in policy loans and other invested assets and $34.2
million in cash and cash equivalents. Bonds are investment grade securities with
fixed incomes ranging in maturity from one to 30 years. The gross average yield
on fixed income bonds as of September 30, 1999 and December 31, 1998 was 6.4%
and 6.3%, respectively. All bonds are considered to be "available for sale". The
Company and its subsidiaries do not invest in high-yield debt instruments,
defined as securities below investment grade with interest rates or yields
significantly above market rates nor does the Company invest in derivatives or
hedging in financial instruments.
Net cash used in operating activities of $39.5 million in 1999 was
primarily the result of claim payments to policyholders, in particular health
claim payments related to the 1998 claim run-off of group medical business,
interactive sales and marketing expenses related to HealthAxis and other
operating expenses.
During 1999 HealthAxis made the final payment of $1.5 million to AOL
under the initial term of Second Amendment to the Amended and Restated
Interactive Marketing Agreement with AOL. Additionally, HealthAxis paid $2.1
million to other Internet partners. Payments to Internet partners are included
in prepaid interactive marketing expense.
Amounts due from reinsurers increased primarily due to delays in the
collection of amounts due under PILIC's 1998 Quota Share arrangements.
In connection with the Company's outsourcing with HPS, the Company
received premiums, net of commissions, HPS fees and certain out of pocket
expenses monthly on or before the 15th of the following month. The $6.8 million
change in amounts due from a third party administrator represented December
1998's net cash settlement collected from HPS in January 1999.
Page 27 of 35 Pages
Future policy benefits and claims of $13.1 million related primarily to
the payment of claims incurred prior to 1999 for the Company's group medical and
group life business. Premiums, claims and expenses incurred on or after January
1, 1999 are 100% ceded to RCH, but the Company retains the liability to pay the
claims incurred prior to 1999.
Non-cash repayment of notes payable represented $1.5 million of
consideration for the Company's sale of MMC Common Stock and for HPS' exercise
of its warrant obtained in 1998 in connection with the HPS E-Commerce Agreement
to purchase 100,000 shares of PAMCO Common Stock for $900 as described in Note K
of the Notes to Financial Statements. Non cash issuance of warrants relates to
HealthAxis as described in Notes E, H and J of the Notes to Financial
Statements.
The statutory capital and surplus of PILIC was $3.5 million at
September 30, 1999, which is $3.5 million below Company Action Level Risk Based
Capital ("RBC") but above Authorized Control Level RBC as calculated at December
31, 1998. The statutory capital and surplus of PILIC, was $4.8 million at
December 31, 1998. At December 31, 1998, PILIC calculated its RBC utilizing a
formula required by the National Association of Insurance Commissioners. The
results of this computation indicate that PILIC's adjusted capital of $5.3
million exceeded Regulatory Action Level but was below Company Action Level as
of December 31, 1998. The RBC formula estimates RBC based on a variety of
historical data including 1998 net earned premium. Accordingly, PILIC's year end
1998 RBC calculation included approximately $4.8 million of RBC related to
PILIC's one life group health and group life business 100% ceded to RCH
effective January 1, 1999. PILIC's 1999 RBC calculation, once calculated for
1999, will be based on 1999 net written premium excluding the business 100%
ceded to RCH. In concept, Risk Based Capital standards are designed to measure
the acceptable amounts of capital an insurer should have based on inherent and
specific risks of the insurers business. This formula is a primary measurement
as to the adequacy of total capital and surplus of life insurance companies.
Since PILIC failed to meet its RBC requirement as of December 31, 1998 it is
subject to regulatory action. Several Departments of Insurance have requested
that PILIC submit a Risk Based Capital Plan ("RBC Plan") because PILIC's
adjusted capital of $5.3 million was below Company Action Level as of December
31, 1998. The goal of PILIC's RBC Plan is for PILIC's adjusted statutory capital
and surplus level to exceed PILIC's Company Action Level RBC. PILIC has
requested regulatory approval for the sale of 545,915 shares of HealthAxis.com,
Inc. Series A Preferred Stock owned by PILIC for $2.8 and a capital contribution
from PAMCO in the amount of $7.2 million as described in Note K. The Company
anticipates that upon the completion of the sale of PILIC to AHC, the Company
will not have any liability with respect to the ongoing insurance, capital and
surplus, and business operations of PILIC. The Company also anticipates that
upon the completion of the closing that the statutory capital and surplus of
PILIC will exceed PILIC's Company Action Level RBC at December 31, 1999.
Insurers failing to meet their RBC requirement may be subject to scrutiny by its
domiciled insurance department and other insurance departments, which the
insurer does business in, and, ultimately, the rehabilitation or liquidation of
PILIC.
During 1999 PILIC did not meet certain minimum capital and surplus
requirements in the states of Florida, Virginia and South Carolina and has been
directed to cease writing new business in those states. Existing inforce
policies in those states are not affected. The Company does not anticipate that
this will have a material impact on the Company in light of the Company's plans
to sell PILIC.
Page 28 of 35 Pages
Administrative rules and legal restrictions of state insurance
departments presently prevent payment of dividends by PILIC to PAMCO without
regulatory approval. Payment of dividends paid by HealthAxis to PAMCO is subject
to restrictions set for in the Certificate of Designation related to HealthAxis
Series A, B, C and D Convertible Preferred Stock. PAMCO and PILIC are also
restricted from paying dividends as described in Note L of the Notes to
Financial Statements. PAMCO, PILIC and HealthAxis do not anticipate paying cash
dividends on Common Stock or on any class of HealthAxis preferred stock in the
foreseeable future.
Impact of Inflation
Inflation increases the need for insurance. Many policyholders who once
had adequate insurance programs increase their life insurance coverage to
provide the same relative financial benefits and protection. The effect of
inflation on medical costs leads to accident and health policies with higher
benefits. Thus, inflation has increased the need for life and accident and
health products.
Higher interest rates, which have traditionally accompanied inflation,
affect the Company's investment operation. The market value of the Company's
fixed rate long-term investments decreases as interest rates increase.
Inflation has significantly increased the cost of health care. The
adequacy of premium rates in relation to the level of health claims is
constantly monitored and, where appropriate, premium rates on such policies,
when appropriate, are increased as policy benefits increase. Failure to make
such increases commensurate with health care cost increases may result in a loss
from the Insurance Operations.
The Company's pre-need products include periodic adjustments to the
face amount of the policy for increases in the consumer price index.
Expenditures and Commitments
During September 1999 PAMCO paid HPS $7,638 to purchase 1,415,000
shares of HealthAxis common stock as described in Note F. PAMCO has agreed to
pay HPS an additional $375 to complete the transaction. In consideration for
PILIC's release of claims against HPS in the amount of $190 owed from HPS to
PILIC, PAMCO agreed to pay PILIC $190. PAMCO anticipates both payments will
occur in 1999.
As described in Note K of the Notes to Financial Statements, PAMCO
entered into a definitive agreement to sell all of the outstanding shares of the
common stock of PILIC to AHC Acquisition, Inc. ("AHC"), a newly formed
Pennsylvania business corporation, which is owned by Alvin H. Clemens, the
Company's Chairman of the Board of Directors. The Agreement calls for PAMCO, at
or prior to closing, to pay $14,700 to PILIC for the purchase of PILIC's home
office building, the purchase of 545,915 shares of HealthAxis.com, Inc. Series A
Preferred Stock and a capital contribution. In addition, PAMCO will transfer to
AHC 100,000 of Series A Convertible Preferred Stock of HealthAxis.com, Inc. in
connection with the obligations assumed by AHC at the closing. PAMCO anticipates
using a portion of the net proceeds from the issuance of convertible debentures
described in Note J of the Notes to Financial Statements to fund its obligations
to PILIC and AHC.
Page 29 of 35 Pages
During the nine months ended September 30, 1999, HealthAxis completed
three private placement offerings, which provided approximately $18.4 million of
cash as described in Notes F, H and I of the Notes to Financial Statements. The
net proceeds have been and are anticipated to be used to fund amounts due under
the Company's distribution agreements with AOL, Lycos, Cnet, Snap and Yahoo!
through the end of fiscal 1999, and the balance is intended to be used by
HealthAxis for its working capital and other general purposes. The Company
believes that the above net proceeds together with its current cash and cash
equivalents will be sufficient to fund HealthAxis' current operations through
the first quarter of 2000. However, subsequent equity or debt financings will be
necessary to enable the Company to fund amounts due to AOL in the event that
HealthAxis elects to exercise its option to renew its agreement with AOL,
payments to Lycos, CNet and Snap, future operations and continue to implement
its current business strategies.
The Company has no material commitments for capital expenditures at
September 30, 1999 but expects such expenditures to total approximately $2.2
million in 1999. Such expenditures will primarily be for equipment, software,
furniture and building improvements. The Company purchased $1.6 million of
property and equipment during the nine months ended September 30, 1999.
HealthAxis has entered into an Interactive Marketing Agreement with AOL
and promotional agreements with CNet, Snap and Lycos. In connection with these
agreements, the Company has paid $15.5 million in cash and warrants as of
September 30, 1999 and is required to pay additional amounts as described in the
Company's Annual Report on Form 10-K/A for the year ended December 31, 1998 in
Notes F, G, H and AA to the Company's Consolidated Financial Statements for the
year ended December 31, 1998.
In August 1999, HealthAxis entered into an Advertising Agreement with
Yahoo!. In connection with this agreement, the Company has paid $150 as of
September 30, 1999 and is required to pay an additional $575 as described in
Note E to the Company's Consolidated Financial Statements for the period ending
September 30, 1999.
The Company does not anticipate paying cash dividends on Common Stock
or on any series or class of HealthAxis stock in the foreseeable future.
Year 2000 compliance
Year 2000 issues are the result of computer programs being written
using two digits rather than four to define the applicable year. In other words,
date-sensitive software may recognize a date using "00" as the year 1900 rather
than the Year 2000. This could result in system failures or miscalculations
causing disruptions in operations, including, among other things, a temporary
inability to process transactions, send invoices, or engage in similar normal
business activities.
Page 30 of 35 Pages
The Company utilizes various computer software programs, operating
systems and vendors whose software programs and communication links ("Computer
Systems") are used in the Company's Insurance Operations and HealthAxis. For the
Company's Insurance Operations these Computer Systems include health insurance
administration provided by HPS, life insurance administration, health claims
discount repricing provided by First Health Group along with financial
accounting and actuarial systems. For HealthAxis, these Computer Systems include
the www.healthaxis.com web site, links to AOL along with the AOL online network,
links to Lycos, CNET, Snap, Yahoo!, Carrier Partners, HPS, First Health Group,
along with HealthAxis' data warehouse. To the extent that the Company's Computer
Systems contain source codes that are unable to appropriately interpret the Year
2000 then some level of modification, or even replacement of such applications
may be necessary. The result of these Year 2000 issues may, if not corrected,
have a significant negative impact on the Company's business.
HealthAxis has established a task force to assess its systems to
determine whether they correctly define the Year 2000 and to determine the
extent to which the systems of its suppliers, Internet partners, Carrier
Partners and other business partners (insofar as they are material to
HealthAxis' business) are subject to the Year 2000 issue. Although HealthAxis
completed this assessment in November 1999 and has performed remedial
procedures, the Company is currently unable to predict the extent to which the
Year 2000 issue will affect its operations or the extent to which it would be
vulnerable to Year 2000 issues affecting its business partners failure to
remediate any Year 2000 issues on a timely basis. The failure of a business
partner to convert systems on a timely basis, in a manner that is compatible
with HealthAxis' systems, could have a material adverse effect on the Company.
HealthAxis does not have a contingency plan in place in the event that it or any
third party in which it engages in business is not Year 2000 compliant. In
addition, policy purchases are made with credit cards, and HealthAxis'
operations may be materially adversely affected to the extent its customers are
unable to use credit cards due to the Year 2000 issues that are not rectified by
the credit card issuers
To date, the Company has eliminated its health administration system by
outsourcing health administration and claims processing to HPS effective
February 1998 and assigning responsibility of the oversight of HPS' health
administration and claims processing along with the Company's former health
agent and underwriting computer systems to CRLC effective December 31, 1998.
To date, the Company has experienced very few Year 2000 problems with
those problems centering on life administration processing. The cost of
programming changes as of September 30, 1999 was less than $132. As described in
Note K of the Notes to Financial Statements, the Company is in the process of
pursuing the reinsurance of its life insurance inforce and the sale of PILIC
prior to year-end. If the Company does not sell its life inforce business it
will need to pursue alternatives including the modification of its life
administration system at a cost yet to be estimated or the effective replacement
of the system by outsourcing the life system at an estimated incremental annual
cost of approximately $300 per year and a one time conversion cost of
approximately $300. There are also business and financial risks associated with
the Company's Year 2000 exposure relating to its life administration system in
that the Company may not be able to transfer the administration of the business
to a Y2K compliant system prior to encountering Y2K problems.
Page 31 of 35 Pages
In the event that the Computer Systems of the Company or any of the
Company's business partners fail or exhibit significant problems as a result of
Year 2000 processing the Company's service to its customers could be disrupted
for a significant amount of time and result in significant lost income to the
Company.
There are risks associated with the Company's Year 2000 exposure
relating to some external vendors with whom the Company depends on material
sales and service processing. Because the Company does not control these vendors
or their resources, the Company can provide no assurance that such vendors will
complete their respective Year 2000 solutions in time for the Company to fully
test system interfaces with them. Although the Company is coordinating its
efforts with vendors to minimize this impact of Year 2000 issues, the Company is
currently unable to predict the extent to which Year 2000 issues will affect its
operations, or the extent to which it would be vulnerable to the failure of its
business partners or other, to remediate any Year 2000 issues on a timely basis.
The Company has begun the process of developing a contingency plan to
address possible Year 2000 risks to its Computer Systems. There can be no
assurance that the Company will successfully implement its contingency plan or
make all of its systems Year 2000 compliant. The Company does not have a
contingency plan in place in the event any third party in which it engages in
business is not Year 2000 compliant.
Recent Sales of Unregistered Securities
The issuance of securities described below were made pursuant to
exemptions from registration pursuant to Section 4(2) of the Securities Act of
1933, as amended, in reliance upon the fact that such sales did not involve a
public offering. As a result, such securities are subject to restrictions on
transfer. During the nine months ended September 30, 1999, the Company entered
into the following sales of unregistered securities of which all dollar amounts
are in whole dollars:
In March 1999 HealthAxis entered into an Amended and Restated Carrier
Partner Agreement with UICI, pursuant to which HealthAxis issued a warrant to
UICI to purchase 150,000 shares of HealthAxis common stock at $4.40 per share,
with a five-year term. See in Note E to the Consolidated Financial Statements
included herein for a further explanation.
In March 1999 HealthAxis completed a private placement of 1,526,412
shares of HealthAxis Series C Cumulative Convertible Preferred Stock to a group
of accredited investors at $5.77 per share for an aggregate purchase price of
$8,807,397, less issuance cost of $683,501. See Note H to the Consolidated
Financial Statements included herein for a further explanation.
In May 1999 HealthAxis entered into a Strategic Alliance Agreement with
First Health Group Corp. ("First Health"), pursuant to which HealthAxis issued a
warrant to First Health for 50,000 shares of HealthAxis common stock at $20.00
per share, with a three-year term. See in Note E to the Consolidated Financial
Statements included herein for a further explanation.
Page 32 of 35 Pages
In May 1999 HealthAxis completed a private placement of 516,051 shares
of HealthAxis common stock to a group of accredited investors at $12.00 per
share for an aggregate purchase price of $6,193,000, less issuance cost of
$2,000. See in Note F to the Consolidated Financial Statements included herein
for a further explanation.
In June 1999 HealthAxis issued a warrant to ING Barring, Inc. ("ING
Barring") for 63,000 shares of HealthAxis common stock at $5.77 per share, with
a five-year term commencing on March 30, 1999. This warrant was issued in
settlement of its obligations pursuant to the engagement letter dated December
22, 1998 between ING Barring and HealthAxis and in connection with the
settlement agreement and mutual release dated June 16, 1999.
No commissions have been paid in connection with the above sales,
except with regard to the HealthAxis Series C Preferred Stock. In connection
therewith a placement fee of $300,000 was paid and warrants as described in the
previous paragraph were issued.
In July 1999 HealthAxis completed a private placement of 333,334 shares
of HealthAxis Series D Preferred Stock issued to Intel Corp at $12 per share for
an aggregate purchase price of $4,000. See in Note I to the Consolidated
Financial Statements included herein for a further explanation.
In September 1999 PAMCO completed a private placement of Convertible
Debentures in the amount of $27,500,000 due September 14, 2002. See in Note J to
the Consolidated Financial Statements included herein for a further explanation.
Page 33 of 35 Pages
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
Not applicable.
Item 2. Change in Securities.
Not applicable.
Item 3. Defaults Upon Senior Securities.
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 5. Other Information.
Not applicable.
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits:
(1) First Amendment To Stock Purchase Agreement between the
Company and ACH Acquisition, Inc. dated October 27, 1999
(b) Reports on Form 8-K:
(1) Item 5 regarding a Stock Purchase Agreement to sell
Provident Indemnity Life Insurance Company by the Company to
AHC Acquisition, Inc., filed August 27, 1999.
(2) Item 5 regarding the $27.5 million private placement
completed by the Company, filed September 22, 1999.
Page 34 of 35 Pages
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Provident American Corporation
By: /s/ Michael Ashker
---------------------------------------------------------
Michael Ashker, President and Chief Executive Officer
By: /s/ Francis L. Gillan III
---------------------------------------------------------
Francis L. Gillan III, Chief Financial Officer, Principal
Accounting Officer and Treasurer
Date: November 15, 1999
Page 35 of 35 Pages